A study for a 4 year old boy who takes Melatonin - from FDA reports


333 males aged 4 (±5) who take the same drug are studied. This is a personalized study for a 4 year old male patient who has Autism. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 18, 2017

333 males aged 4 (±5) who take Melatonin are studied.

Number of reports submitted per year:

Melatonin for a 4-year old boy.

Information of the patient in this study:

  • Age: 4
  • Gender: male
  • Conditions: Autism
  • Drugs taken:
    • Melatonin (melatonin)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Dysphagia: 5 (1.5% of males aged 4 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • drowsiness
  • hyperammonaemia
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  • headache
  • agitation
  • drug ineffective
  • abnormal behavior
  • fever
  • drowsiness
  • fatigue
  • crying
  • seizures
  • aggression

Top conditions involved for these people *:

  • Attention Deficit Hyperactivity Disorder (109 people, 32.73%)
  • Epilepsy (22 people, 6.61%)
  • Constipation (17 people, 5.11%)
  • Mucopolysaccharidosis Ii (12 people, 3.60%)
  • Poor Quality Sleep (11 people, 3.30%)

Top co-used drugs for these people *:

  • Daytrana (46 people, 13.81%)
  • Keppra (42 people, 12.61%)
  • Onfi (25 people, 7.51%)
  • Miralax (23 people, 6.91%)
  • Depakote (23 people, 6.91%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

  • Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts) can be treated by Risperdal, Abilify, Risperidone, Invega, Lexapro (latest reports from 3,623 Autism patients)

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Melatonin, Dysphagia Autism

You may be interested in these posts

More posts for: Melatonin, Dysphagia Autism